203 related articles for article (PubMed ID: 11719280)
1. Identification of novel oestrogen receptor target genes in human ZR75-1 breast cancer cells by expression profiling.
Soulez M; Parker MG
J Mol Endocrinol; 2001 Dec; 27(3):259-74. PubMed ID: 11719280
[TBL] [Abstract][Full Text] [Related]
2. Expression and regulation of Cyr61 in human breast cancer cell lines.
Tsai MS; Bogart DF; Li P; Mehmi I; Lupu R
Oncogene; 2002 Jan; 21(6):964-73. PubMed ID: 11840342
[TBL] [Abstract][Full Text] [Related]
3. Molecular changes associated with the acquisition of oestrogen hypersensitivity in MCF-7 breast cancer cells on long-term oestrogen deprivation.
Chan CM; Martin LA; Johnston SR; Ali S; Dowsett M
J Steroid Biochem Mol Biol; 2002 Aug; 81(4-5):333-41. PubMed ID: 12361723
[TBL] [Abstract][Full Text] [Related]
4. Estradiol-induced vascular endothelial growth factor-A expression in breast tumor cells is biphasic and regulated by estrogen receptor-alpha dependent pathway.
Sengupta K; Banerjee S; Saxena N; Banerjee SK
Int J Oncol; 2003 Mar; 22(3):609-14. PubMed ID: 12579315
[TBL] [Abstract][Full Text] [Related]
5. Characterization of new estrogen receptor destabilizing compounds: effects on estrogen-sensitive and tamoxifen-resistant breast cancer.
Hoffmann J; Bohlmann R; Heinrich N; Hofmeister H; Kroll J; Künzer H; Lichtner RB; Nishino Y; Parczyk K; Sauer G; Gieschen H; Ulbrich HF; Schneider MR
J Natl Cancer Inst; 2004 Feb; 96(3):210-8. PubMed ID: 14759988
[TBL] [Abstract][Full Text] [Related]
6. mRNA expression of the type I growth factor receptors in the human breast cancer cells MCF-7: regulation by estradiol and tamoxifen.
Revillion F; Pawlowski V; Lhotellier V; Louchez MM; Peyrat JP
Anticancer Res; 2003; 23(2B):1455-60. PubMed ID: 12820409
[TBL] [Abstract][Full Text] [Related]
7. PDZK1 and GREB1 are estrogen-regulated genes expressed in hormone-responsive breast cancer.
Ghosh MG; Thompson DA; Weigel RJ
Cancer Res; 2000 Nov; 60(22):6367-75. PubMed ID: 11103799
[TBL] [Abstract][Full Text] [Related]
8. Impact of the nuclear receptor coactivator AIB1 isoform AIB1-Delta3 on estrogenic ligands with different intrinsic activity.
Reiter R; Oh AS; Wellstein A; Riegel AT
Oncogene; 2004 Jan; 23(2):403-9. PubMed ID: 14691461
[TBL] [Abstract][Full Text] [Related]
9. Various phosphorylation pathways, depending on agonist and antagonist binding to endogenous estrogen receptor alpha (ERalpha), differentially affect ERalpha extractability, proteasome-mediated stability, and transcriptional activity in human breast cancer cells.
Marsaud V; Gougelet A; Maillard S; Renoir JM
Mol Endocrinol; 2003 Oct; 17(10):2013-27. PubMed ID: 12855746
[TBL] [Abstract][Full Text] [Related]
10. Altered expression of estrogen-regulated genes in a tamoxifen-resistant and ICI 164,384 and ICI 182,780 sensitive human breast cancer cell line, MCF-7/TAMR-1.
Lykkesfeldt AE; Madsen MW; Briand P
Cancer Res; 1994 Mar; 54(6):1587-95. PubMed ID: 8137264
[TBL] [Abstract][Full Text] [Related]
11. Use of global gene expression patterns in mechanistic studies of oestrogen action in MCF7 human breast cancer cells.
Sadler AJ; Pugazhendhi D; Darbre PD
J Steroid Biochem Mol Biol; 2009 Mar; 114(1-2):21-32. PubMed ID: 19167489
[TBL] [Abstract][Full Text] [Related]
12. Association of interferon regulatory factor-1, nucleophosmin, nuclear factor-kappaB, and cyclic AMP response element binding with acquired resistance to Faslodex (ICI 182,780).
Gu Z; Lee RY; Skaar TC; Bouker KB; Welch JN; Lu J; Liu A; Zhu Y; Davis N; Leonessa F; Brünner N; Wang Y; Clarke R
Cancer Res; 2002 Jun; 62(12):3428-37. PubMed ID: 12067985
[TBL] [Abstract][Full Text] [Related]
13. Molecular cloning and characterization of the human WISP-2/CCN5 gene promoter reveal its upregulation by oestrogens.
Fritah A; Redeuilh G; Sabbah M
J Endocrinol; 2006 Dec; 191(3):613-24. PubMed ID: 17170219
[TBL] [Abstract][Full Text] [Related]
14. Regulation of estrogen receptor expression in breast cancer.
Martin MB; Saceda M; Lindsey RK
Adv Exp Med Biol; 1993; 330():143-53. PubMed ID: 8368130
[TBL] [Abstract][Full Text] [Related]
15. The oestrogen-like effect of 4-hydroxytamoxifen on induction of transforming growth factor alpha mRNA in MDA-MB-231 breast cancer cells stably expressing the oestrogen receptor.
Levenson AS; Tonetti DA; Jordan VC
Br J Cancer; 1998 Jun; 77(11):1812-9. PubMed ID: 9667651
[TBL] [Abstract][Full Text] [Related]
16. Effects of 4-hydroxytamoxifen and a novel pure antioestrogen (ICI 182780) on the clonogenic growth of human breast cancer cells in vitro.
DeFriend DJ; Anderson E; Bell J; Wilks DP; West CM; Mansel RE; Howell A
Br J Cancer; 1994 Aug; 70(2):204-11. PubMed ID: 8054267
[TBL] [Abstract][Full Text] [Related]
17. Alternative splicing of the estrogen receptor primary transcript normally occurs in estrogen receptor positive tissues and cell lines.
Pfeffer U; Fecarotta E; Arena G; Forlani A; Vidali G
J Steroid Biochem Mol Biol; 1996 Jan; 56(1-6 Spec No):99-105. PubMed ID: 8603053
[TBL] [Abstract][Full Text] [Related]
18. A novel estrogen receptor variant mRNA lacking exons 4 to 6 in breast carcinoma.
Chan CM; Dowsett M
J Steroid Biochem Mol Biol; 1997 Aug; 62(5-6):419-30. PubMed ID: 9449245
[TBL] [Abstract][Full Text] [Related]
19. MicroRNA-221/222 confers breast cancer fulvestrant resistance by regulating multiple signaling pathways.
Rao X; Di Leva G; Li M; Fang F; Devlin C; Hartman-Frey C; Burow ME; Ivan M; Croce CM; Nephew KP
Oncogene; 2011 Mar; 30(9):1082-97. PubMed ID: 21057537
[TBL] [Abstract][Full Text] [Related]
20. Studies on the development of resistance to the pure antiestrogen Faslodex in three human breast cancer cell lines.
Sommer A; Hoffmann J; Lichtner RB; Schneider MR; Parczyk K
J Steroid Biochem Mol Biol; 2003 May; 85(1):33-47. PubMed ID: 12798355
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]